Thrivent Financial For Lutherans Harmony Biosciences Holdings, Inc. Transaction History
Thrivent Financial For Lutherans
- $52.6 Billion
- Q3 2024
A detailed history of Thrivent Financial For Lutherans transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 23,655 shares of HRMY stock, worth $795,517. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,655
Previous 26,402
10.4%
Holding current value
$795,517
Previous $797,000
18.7%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding HRMY
# of Institutions
243Shares Held
45.2MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$377 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$196 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$117 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$87.6 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$64.8 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.99B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...